Last Price$70.2(2.4%)
Market Cap$25.7B
LTM Research & Development Expenses (R&D)
$360.0M
YoY Growth
+4.7%
3Y CAGR
N/A
5Y CAGR
+12.3%
Stock quality & Intrinsic value
5/10
33.4% undervalued
The Estée Lauder Companies Inc. Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $146.8M | $157.9M | $178.0M | $191.3M | $179.0M | $181.0M | $202.0M | $228.0M | $243.0M | $307.0M | $344.0M | $360.0M |
Overvalued or undervalued?
Check the intrinsic value for EL
and see if it's the right time to invest.
The Estée Lauder Companies Inc. (EL) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
The Estée Lauder Companies Inc.EL
$360.0M
4.7%
N/A
12.3%
Median Peer Set
$71.0M
(24.9%)
(2.1%)
(0.7%)
Unilever PLCUL
$1,026.6M
(44.5%)
(19.2%)
(13.8%)
Kenvue Inc.KVUE
$205.0M
(48.6%)
26.2%
N/A
The Clorox CompanyCLX
$127.0M
(5.2%)
(4.1%)
(1.4%)
Coty Inc.COTY
$126.8M
20.5%
9.5%
N/A
Hims & Hers Health, Inc.HIMS
$78.8M
63.4%
88.3%
N/A
Church & Dwight Co., Inc.CHD
$63.1M
(48.4%)
(15.7%)
(7.6%)
e.l.f. Beauty, Inc.ELF
$0.0
N/A
N/A
N/A
Colgate-Palmolive CompanyCL
$0.0
(100.0%)
(100.0%)
(100.0%)
Kimberly-Clark CorporationKMB
$0.0
(100.0%)
(100.0%)
(100.0%)
The Procter & Gamble CompanyPG
$0.0
N/A
N/A
N/A
EL key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 6,336.3 9.4% | 6,463.8 2.0% | 7,037.5 8.9% | 7,910.8 12.4% | 7,323.8 (7.4%) | 7,795.8 6.4% | 8,810.0 13.0% | 9,713.6 10.3% | 10,181.7 4.8% | 10,968.8 7.7% | 10,780.4 (1.7%) | 11,262.3 4.5% | 11,824.0 5.0% | 13,683.0 15.7% | 14,863.0 8.6% | 14,294.0 (3.8%) | 16,215.0 13.4% | 17,737.0 9.4% | 15,910.0 (10.3%) | 15,608.0 (1.9%) |
| Cost of Goods Sold (COGS) | 1,617.4 | 1,686.6 | 1,774.8 | 1,996.8 | 1,881.6 | 1,829.4 | 1,936.9 | 1,995.8 | 2,025.9 | 2,158.2 | 2,100.6 | 2,181.1 | 2,437.0 | 2,844.0 | 3,387.0 | 3,552.0 | 3,834.0 | 4,305.0 | 4,564.0 | 4,424.0 |
% margin | 4,718.9 74.5% | 4,777.2 73.9% | 5,262.7 74.8% | 5,914.0 74.8% | 5,442.2 74.3% | 5,966.4 76.5% | 6,873.1 78.0% | 7,717.8 79.5% | 8,155.8 80.1% | 8,810.6 80.3% | 8,679.8 80.5% | 9,081.2 80.6% | 9,387.0 79.4% | 10,839.0 79.2% | 11,476.0 77.2% | 10,742.0 75.2% | 12,381.0 76.4% | 13,432.0 75.7% | 11,346.0 71.3% | 11,184.0 71.7% |
| Operating Expenses | 3,998.3 | 4,157.6 | 4,512.8 | 5,103.3 | 5,023.8 | 5,067.0 | 5,696.7 | 6,324.8 | 6,597.0 | 6,985.9 | 7,073.5 | 7,337.8 | 7,469.0 | 8,556.0 | 8,857.0 | 8,637.0 | 9,371.0 | 9,888.0 | 9,575.0 | 10,214.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 146.8 | 157.9 | 178.0 | 191.3 | 179.0 | 181.0 | 202.0 | 228.0 | 243.0 | 307.0 | 344.0 | 360.0 |
| Selling, General & Administrative Expenses (SG&A) | 3,998.3 | 4,065.5 | 4,511.7 | 5,102.9 | 4,883.9 | 5,067.0 | 5,696.7 | 6,324.8 | 6,597.0 | 6,985.9 | 7,073.5 | 7,337.8 | 7,469.0 | 8,556.0 | 8,857.0 | 8,637.0 | 9,371.0 | 9,888.0 | 9,575.0 | 9,621.0 |
% margin | 720.6 11.4% | 619.6 9.6% | 749.9 10.7% | 810.7 10.2% | 418.4 5.7% | 789.9 10.1% | 1,089.4 12.4% | 1,311.7 13.5% | 1,526.0 15.0% | 1,827.6 16.7% | 1,606.3 14.9% | 1,610.3 14.3% | 1,692.0 14.3% | 2,052.0 15.0% | 2,313.0 15.6% | 2,706.0 18.9% | 3,896.0 24.0% | 3,170.0 17.9% | 1,509.0 9.5% | 970.0 6.2% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.3 | 15.6 | 28.0 | 56.0 | 58.0 | 48.0 | 51.0 | 30.0 | 131.0 | 167.0 |
| Interest Expense | 13.9 | 23.8 | 38.9 | 66.8 | 75.7 | 101.6 | 63.9 | 61.1 | 54.8 | 50.8 | 60.0 | 70.7 | 103.0 | 128.0 | 133.0 | 161.0 | 173.0 | 167.0 | 255.0 | 378.0 |
| Pre-tax Income | 706.7 | 595.8 | 711.0 | 743.9 | 334.3 | 688.3 | 1,025.5 | 1,261.1 | 1,475.2 | 1,776.8 | 1,560.6 | 1,555.2 | 1,617.0 | 1,980.0 | 2,307.0 | 1,046.0 | 3,331.0 | 3,036.0 | 1,397.0 | 772.0 |
% effective tax rate | 291.3 41.2% | 259.7 43.6% | 255.2 35.9% | 259.9 34.9% | 115.9 34.7% | 205.9 29.9% | 321.7 31.4% | 400.6 31.8% | 451.4 30.6% | 567.7 32.0% | 467.2 29.9% | 434.4 27.9% | 361.0 22.3% | 863.0 43.6% | 513.0 22.2% | 350.0 33.5% | 456.0 13.7% | 628.0 20.7% | 387.0 27.7% | 363.0 47.0% |
% margin | 406.1 6.4% | 244.2 3.8% | 449.2 6.4% | 473.8 6.0% | 218.4 3.0% | 478.3 6.1% | 700.8 8.0% | 856.9 8.8% | 1,019.8 10.0% | 1,204.1 11.0% | 1,088.9 10.1% | 1,114.6 9.9% | 1,249.0 10.6% | 1,108.0 8.1% | 1,785.0 12.0% | 684.0 4.8% | 2,870.0 17.7% | 2,390.0 13.5% | 1,006.0 6.3% | 390.0 2.5% |
| EPS | 0.90 | 0.57 | 1.10 | 1.22 | 0.56 | 1.21 | 1.78 | 2.20 | 2.63 | 3.12 | 2.87 | 3.01 | 3.40 | 3.01 | 4.91 | 1.90 | 7.91 | 6.64 | 2.81 | 1.09 |
| Diluted EPS | 0.89 | 0.56 | 1.08 | 1.20 | 0.55 | 1.19 | 1.74 | 2.16 | 2.58 | 3.06 | 2.82 | 2.96 | 3.35 | 2.95 | 4.82 | 1.86 | 7.79 | 6.55 | 2.79 | 1.08 |
% margin | 917.3 14.5% | 818.0 12.7% | 957.1 13.6% | 1,061.4 13.4% | 686.0 9.4% | 1,053.6 13.5% | 1,383.8 15.7% | 1,618.0 16.7% | 1,866.9 18.3% | 2,209.3 20.1% | 2,030.1 18.8% | 2,059.0 18.3% | 2,340.0 19.8% | 2,789.0 20.4% | 3,159.0 21.3% | 2,712.0 19.0% | 3,661.0 22.6% | 3,787.0 21.4% | 2,350.0 14.8% | 1,980.0 12.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D)?
As of today, The Estée Lauder Companies Inc.'s last 12-month Research & Development Expenses (R&D) is $360.0M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D) growth rate?
Over the last year, The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D) growth was 4.7%. The average annual Research & Development Expenses (R&D) growth rates for The Estée Lauder Companies Inc. have been N/A over the past three years, 12.3% over the past five years.
3) Is The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D) growth rate Good?
Over the last year, The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D) growth was 4.7%, which is higher than industry growth of (0.9%). It indicates that The Estée Lauder Companies Inc.'s Research & Development Expenses (R&D) growth is Bad.